Chitosan in Combination with Ascorbic Acid (vitamin C) Promotes Further Weight Loss

 


Fat uptake in the body in presence of chitosan oligosaccharide may be even more decreased by adding to the latter ascorbic acid (vitamin C).

Chitosan oligosaccharide, creating a salt bond with ascorbic acid, forms chitosan oligosaccharide ascorbate and thus stabilizes quite an unstable vitamin C, i.e. it acts as a carrier for ascorbic acid. Under the influence of the stomach hydrochloric acid there occurs proteinization of chitosan oligosaccharide and release of ascorbic acid.

Some of researchers suggest that decrease of fat absorption in presence of chitosan oligosaccharide ascorbate can be explained by synergetic action of ascorbic acid and chitosan oligosaccharide.

Chitosan oligosaccharide ascorbate is capable of controlling cholesterol synthesis by metabolism activation. Moreover, chitosan oligosaccharide ascorbate application enhances immunological functions of the body.

Chitosan oligosaccharide ascorbate may be used alone as well as in composition with other biologically active substances for preparing various BAS (for more information concerning Chitosan and weight loss please see page 7).

Saw Palmetto in the Prevention Benign Prostatic Hyperplasia
 

The incidence of prostate gland disorders increases each year in men after the age of 40. Problems associated with prostate disorders can range from uncomfortable inflammation and increased urinary frequency to cancer and death.

Prostate cancer is the most common cancer among American men and is the second leading cause of cancer deaths after lung cancer. The American Cancer Society predicts that this year 209,900 cases of prostate cancer will be newly diagnosed, and that approximately 41,800 men will die from this disease.

Several natural products are effective in preventing and/or treating these conditions. These include: extracts of the herbs saw palmetto, Pygeum africanum and stinging nettles root; the minerals zinc and selenium; and a diet high in vegetables containing lycopene.

Benign prostatic hyperplasia (BPH) denotes an enlargement of the prostate gland. This non-cancerous condition occurs in half of men between the ages of 40 and 59, and in 80 percent of men over age 70. The first sign of clinical BPH is usually the need to urinate frequently during the night. As the condition progresses, many men also develop a slight pain or burning sensation during urination as well as difficulty starting the flow of urine. There is also a noticeable decrease in the force of the urine stream. As the gland enlarges further, it begins to squeeze or pinch off the urethra, obstructing urination (for more information concerning Saw Palmetto's effect on Benign Prostatic Hyperplasia please see page 3)